Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | KWR | Common Stock | Options Exercise | $100K | +702 | +6.88% | $142.38 | 10.9K | May 12, 2023 | Direct | |
transaction | KWR | Common Stock | Sale | -$141K | -702 | -6.44% | $201.55 | 10.2K | May 12, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | KWR | Employee Stock Option (right to buy) | Options Exercise | $0 | -702 | -16.59% | $0.00 | 3.53K | May 12, 2023 | Common Stock | 702 | $142.38 | Direct | F2 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.4839 to $201.86, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. |
F2 | The options for this grant vest in three annual installments: 1,410 shares on March 16, 2023; 1,410 shares on March 16, 2024; and 1,411 shares on March 16, 2025. |